Solid-Phase Peptide Synthesis (SPPS)

Solid-phase peptide synthesis anchors the C-terminal residue to an insoluble resin bead and extends the chain toward the N-terminus one residue at a time. Each cycle removes the temporary N-alpha protecting group, couples the next activated amino acid in large excess, and washes the surplus away by filtration. Once the sequence is complete, strong acid cleaves the peptide from the resin and strips the side-chain protecting groups, usually in the same operation.

Robert Bruce Merrifield introduced the method in 1963 and received the Nobel Prize in Chemistry for it in 1984. Its limitation is arithmetic, because yields multiply. At 99 percent efficiency per coupling, a 30-residue chain retains roughly 74 percent full-length material; at 98 percent, closer to 55 percent. That compounding is why practical stepwise synthesis thins out around 50 residues, and why 30- to 40-residue incretin analogues sit at the demanding end of the range.

The mechanism explains the impurity profile on any certificate. Incomplete couplings produce deletion sequences, terminated chains produce truncations, epimerisation during activation produces diastereomers, and scavenger and protecting-group chemistry during cleavage produces adducts. All of these are structurally close to the target, which is exactly why they resist chromatographic removal and why purification, not assembly, sets the cost of a long peptide.

Naming the method is not a quality claim. Nearly every synthetic research peptide is made this way, so stating it distinguishes nothing, and crude material from a long sequence can be well under 70 percent full-length before purification. Treating one purity specification as equally credible for a five-residue peptide and a 39-residue one ignores the yield arithmetic that makes them very different manufacturing problems.